StocksVeracyte IncVCYT

VCYT

Veracyte Inc

17.94 -0.43 (-2.34%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
17.92
B
17.98

Overview

Prev Close17.94
Day's Range 17.51 - 18.59
52 Week Range 14.79 - 53.92
Average Volume (3m)982.47K
1-Year Return-51.87%
Beta1.6146
Market Cap1.31B
P/E Ratio
Revenue250.59M
EPS-0.688
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.713/12/202123/02/202204/05/202220.0025.0030.0035.0040.0045.00
Chart times in UTC
Industry Biotechnology
CEO Marc A. Stapley
Employees 761

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Veracyte Inc's revenues increased by 0.66% and amounted to 67.78M. Net income decreased by 37.36% to -14.46M. Net assets decreased by 1.03% to 1.09B and EPS decreased from -0.15 to -0.20.
VCYT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.02%
Net Profit Margin
-28.54%
Operating Margin
-15.79%
Return On Investment
-18.34%
06/21
09/21
12/21
03/22
Total Revenue
55.11M
60.37M
67.34M
67.78M
Gross Profit
33.42M
38.73M
44.45M
38.77M
Operating Income
-7.47M
-16.68M
-12.33M
-10.31M
Net Income
-9.04M
-14.13M
-10.53M
-14.46M